Wednesday, May 4, 2011

Former Onyx boss Renton joins Affymax board - Pittsburgh Business Times:

http://homeworker.blog.com/2011/05/04/bamboo-floors/
Hematide is in a Phase III trial. Renton led Onyx for nearlh 15 years, stepping down in Februar 2008as president, CEO, chairman and a membed of Onyx’s board. At the company, he helped negotiate a development and commercialization partnership with that resultef inthe anti-cancer drug Nexavar tablets, which cost about $5,000 a montjh in the United Statexs and are approaching $1 billion in annual sales, are approved in more than 80 countriese to treat kidney cancer and 70-plus countries for livet cancer. Prior to joining Onyx, Rento was president and COO of which acquired Cetusin 1991. Renton had been presidenrt of Cetussince 1990, COO since 1987 and CFO from 1983 to 1987.
Rentonh also serves on the boardsof , Cepheid and the Special Olympiczs of Northern California.

No comments:

Post a Comment